1. Synthesis of polyglutamate derivatives from radioactively labelled folic acid, folinic acid and methotrexate has been studied in human phytohaemagglutinin-transformed lymphocytes.
Introduction
There is now strong evidence that the natural coenzymes of folate in mammalian cells are the polyglutamate derivatives of the reduced folate compounds. Folate polyglutamates form almost all the intracellular folates in mammalian cells, including those in resting and rapidly proliferating phases (Lavoie, Tripp, Parsa & Hoffbrand, 1975) . Direct biochemical studies in which folate polyglutamate and folate monoglutamate derivatives have been compared as coenzyme in folatsmediated reactions in mammalian systems have invariably shown that the polyglutamate derivative is more active (Blakley, 1957; Coward, Parameswaran, Cashmore & Bertino, 1974; Coward, Chello, cashmore, Parammaran, D e Angelis & Bertino, 1975; Cheng & Stokstad, 1975) . Moreover, a strain of Chinese hamster cell which is able to incorporate folate monoglutamate but unable to synthesize folate polyglutamates, requires extra thymidine, adenosine and glycine for growth, compounds whose synthesis requires folatemediated reactions (McBurney & Whitmore, 1974a, b) .
In view of all these observations, the mechanism of synthesis of the folate polyglutamate derivatives assumes considerable interest. Studies of synthesis of polyglutamate derivatives of folate from labelled folk acid have now been carried out in vivo in the guinea-pig, rat and monkey (Corrocher, Bhuyan & Hoffbrand, 1972; Houlihan & Scott, 1972; Shin, Williams & Stokstad, 1972; Shin, Buehring & Stokstad, 1974; Brown, Davidson & Scott, 1974a, b; Leslie & Baugh, 1974) . Folate polyglumate synthesis has also been studied in vitro with a semipurified cell extract from Neurospora crassa (Sakami, Ritari, Black & Rzepka, 1973; Ritari, Sakami, Black & Rzepka, 1975) and from rat liver (Spronk, 1973) and in a broken cell extract of sheep liver (Gawthorne &Smith, 1974) .
In the only studies of folate polyglutamate synthesis in human cells so far reported, Lavoie, Tripp & Hoffbrand (1974) found that human phytohaemagglutinin-stimulated lymphocytes synthesize labelled folate polyglutamate derivatives from [3H]folic acid in vitro over a 72 h period and that the synthesis with labelled folic acid used as precursor was not impaired by vitamin Brz deficiency. Indirect evidence in these studies suggested that methyltetrahydrofolate was not the direct substrate for the folate polyglutamatesynthesizing enzyme but that the methyl group was removed before polyglutamate synthesis occurred, a 'demethylation' which presumably requires vitamin
In the present studies, we report the size of polyglutamates formed in human cells from tritiumlabelled folic acid (pteroylglutamic acid) and tritiumlabelled folinic acid (5-formyltetrahydrofolic acid), the time-course of synthesis of labelled folate polyglutamates in human cells and effects of methotrexate on this process. In addition. synthesis of labelled polyglutamates from tritium-labelled methotrexate itself has been found to occur in human cells.
An abstract of part of this work has been published (Lavoie & Hoffbrand, 1974) .
Biz.
Materials and methods
Lymphocytes were obtained from venous blood collected from normal adult volunteers, separated by the Triosil-Ficoll method (Boyum, 1968) and cultured with phytohaemagglutinin over a 72 h period as described by Das & Hoffbrand (1970) . Labelled precursors were added, 2 ,uCi in 20 h u l of sodium chloride (150 mmol/l) to each of the 3 ml culture bottles containing 3 x 10' cells. Tritiated folic acid ([3',5',9(n) (Buehring, Tamura & Stokstad, 1974) , were kindly supplied by Dr E. L. R. Stokstad, Dr K. U. Buehring and Dr J. Perry. These were purified by DEAE-cellulose chromatography and de-salted with Sephadex G-25. At the end of the incubation period, the cells were harvested by centrifugation at 2000 rev./min for 5 min at 4"C, washed three times with cold (4°C) TC 199 (Wellcome) and suspended in 3 ml of potassium phosphate buffer (0.1 molll), pH 8.5, containing 0.057 mol of ascorbic acid/l and 0.2 mol of 2-mercaptoethanol/l and autoclaved at 115°C for 5 min. The extract was centrifuged; the supernatant, together with one wash of the protein deposit with 1 ml of potassium phosphate buffer, was stored at 4°C. Further washing of the protein deposit extracted less than 1 % ofthe tota1d.p.m. A quantity (1 me) of non-radioactive folic acid, folinic acid or methotrexate to act as a column marker was added before adding 16 ml of potassium permanganate (0.127 mol/l) at pH 9.0 to cleave the folates at the C-9-N-10 bond as described by Houlihan & Scott (1972) . The resulting labelled p-aminobenzoylglutamate derivatives were chromatographed on a DEAE-cellulose column with a potassium chloride gradient (Brown et al., 1974a) . One hundred fractions were collected and the radioactivity in each was counted (Lavoie et al., 1974) , and the positions of the cold marker checked by [8HlFolic acid (2 pCi) was added to each 3 ml culture bottle containing 3 x loo normal lymphocytes and phytohaemagglutinin. In this experiment, a total of 21 x 10' lymphocytes were cultured. After 72 h incubation at 3 7 T , the cells were harvested; folate was extracted, cleaved by potassium permanganate and chromatographed. Vertical scale = d.p.m. from 2.5 ml of each 3.8 ml fraction. There are also substantial amounts of labelled tri-and hexa-glutamate. For the purpose of expressing a proportion of the total radioactivity in each peak, the radioactivity which chromatographed before the monoglutamate peak, which amounted to 8.9 k 7.6 SD% of the total radioactivity recovered from the column (Table l) , has been ignored. The exact identity of this early eluting radioactivity, presumably derived from breaking-down folates, is uncertain. The recovery of radioactivity from the columns during the gradient averaged 79.7%; the remaining radioactivity largely left the column before cornmencement of the gradient.
Results

Formation of folate polyglutamate derivatives
When [3H]folinic acid was incubated with cells for 72 h, the proportion of labelled folates in the different polyglutamate peaks was different ( Table 1) . Folate pentaglutamates formed by far the largest peak (mean 31.8%) with smaller (between 10.7 and 16.0%) quantities of tetra-, tri-, di-and monoglutamate and only 7.3% hexa-and septa-glutamate. The proportion of labelled folate monoglutamate in the cell was also less than after incubation of the cells for 72 h with E3H]folic acid (Tables 1 and 2) . Table 2 summarizes the data for the time-course of formation of labelled cell folates from labelled folic acid and folinic acid. Each point is the mean value from six culture bottles. With [3H]folic acid in the external medium and after 4 h, nearly 90% of the radioactively labelled folate in the cells is still in the monoglutamate form but small amounts of polyglutamates of folate, up to the septaglutamate, are also present. After 24 h incubation, substantially less folate monoglutamate remains and increased proportions of folate polyglutamate derivatives are present. After 72 h, the pattern is similar but with the proportion of penta-, hexa-and septa-glutamate somewhat higher and the proportion of mono-, diand tetra-glutamate somewhat lower. There was considerably more rapid formation of folate polyglutamate derivatives with [3H]folinic acid in the external medium, and after 4 h the proportions of labelled higher polyglutamates was only slightly less than after 24 h or 72 h incubation periods ( Table 2) . Table 3 shows the results of four experiments in which labelled methotrexate has been incubated with phytohaemagglutinin-stimulated lymphocytes between 48 and 72 h of culture. Small quantities of radioactivity chromatographing in the positions of the di-(4-5%), tri-(1.5%) and tetra-glutamate (1 % markers and traces of label chromatographing as pentaglutamate derivatives of methotrexate were present. The polyglutamate nature of these derivatives was confirmed by pre-incubation of the lymphocyte extracts with plasma conjugase, which completely eliminated the peaks after the glutamate 1 (Glul) marker but did not remove the peak chromatographing as Glul.
Formation of methotrexate polyglutamate drivatives
Effect of methotrexate on formation of polyglutamate derivatives from labelled folic acid and folinic acids
In these experiments, non-radioactive methotrexate (10 mmol/l) was added at 45 h of culture, labelled folic acid or folinic acid was added at 48 h and the folates were extracted at 72 h. Some polyglutamate derivatives were formed from [ 3H]folic acid in the presence of methotrexate (Table 4) . The total uptake of ['Hlfolic acid into the cells was diminished to approximately a third by methotrexate (Table 4) , however, and the only radioactive peaks considered to be polyglutamate derivatives were distinct peaks of tri-and tetra-glutamate and a trace of di-glutamate. No label chromatographing as higher folate polyglutamate derivatives was detectable. On the other hand, when labelled folinic acid was used as substrate for folate polyglutamate synthesis, methotrexate had no effect on the formation of polyglutamate derivatives and the uptake of labelled folinic acid was greater in the presence of methotrexate than in control cultures ( Table 4) .
Discussion
The results of this study show that human phytohaemagglutinin-stimulated lymphocytes are able to form derivatives from labelled folic acid, labelled folinic acid and from labelled methotrexate, which, after heat extraction and permanganate oxidation, chromatographed on DEAE-cellulose in positions corresponding to similarly treated folate polyglutamate markms. These peaks, which are removed by prior incubation at pH 4.6 with plasma, are considered to be polyglutamate derivatives of the labelled precursors. The studies with folic acid as substrate show that after 72 h approximately equal quantities of mono-, tetra-, penta-and hexa-glutamate are present in lymphocytes. It is unlikely, however, that this pattern is identical with that of the endogenous lymphocyte folates since the labelled precursor was left in contact with the cells until the time of extraction. It is apparent from the time-course studies that cells are able to accumulate [3H]folic acid more rapidly than they are able to convert this into polyglutamate derivatives. A major part of the delay may be due to delay in reduction of folic acid to tetrahydrofolate since when identical experiments were carried out with a fully reduced folate, folinic acid (5-formyltetrahydrofolate), as precursor, much smaller quantities of labelled monoglutamate could be detected after 72 h. Moreover, the pattern of the polyglutamate derivatives that were found after incubation with [3H]folinic acid for as short a period as 4 h showed only slightly less of the incorporated labelled folate in the higher folate polyglutamate fractionscompared with24 or 72 hincubation results. Previous studies in animals have all used labelled folic acid as precursor and have suggested that it takes several days for equilibration with endogenous folate Brown et al., 1974a, b; Leslie & Baugh, 1974) . Though the present studies do not provide a study of equilibration of the labelled precursor with endogenous human folates, they do suggest that in proliferating human cells, at least, folate polyglutamate formation occurs quite rapidly, over a period of hours or possibly even over a shorter period, once the folate monoglutamate precursor has been fully reduced.
The reason for the consistent quantitative differences in the proportions of label in the folate polyglutamate peaks of different sizes with folk acid or folinic acid as precursor is difficult to explain. This does not seem to be due to an artifact produced by the permanganate oxidation technique, since using the zinc reduction technique of Baugh, Braverman & Nair (1974) to cleave the C-9-N-10 bond before chromatography gave the same differences in chromatographic patterns to those found with the oxidation technique. Part of the difference may be due to the relative speeds of incorporation of non-reduced and reduced folate into the polyglutamate fractions.
At all events, the conclusion from both labelled precursor studies that the main forms of folate in human lymphocytes and presumably in other human cells are tetra-, penta-and hexa-glutamate is consistent with the finding in other mammalian tissues (Shin et al., 1972; Houlihan &Scott, 1972; Brown et al., 1974a, b) in rat, guinea-pig, hamster and monkey, in which penta-and hexa-glutamate have been found to predominate in the liver and kidney. The effects of methotrexate on polyglutamate formation from labelled folic acid in human lymphocytes is very similar to that reported by in the guinea-pig. They found that some unreduced polyglutamate derivatives of folic acid could be formed from labelled folk acid despite the presence of methotrexate. Their work has been supported by the findings of Shin et al. (1974) and Garth & Baugh (1974) (Sakami et al., 1973) and rat liver (Spronk, 1973) have suggested that tetrahydrofolate rather than methyltetrahydrofolate or any other reduced derivative is the optimum substrate for the polyglutamate-synthesizing enzyme, though in sheep liver Gawthorne & Smith (1974) did find that methyltetrahydrofolate itself could act as substrate. Studies in vitro are now necessary to determine the optimum substrate for folate polyglutamate synthesis in human cells.
